Release Date: 02/05/16 08:36 Summary: Investor Presentation-TV2.AX Price Sensitive: No Download Document 2.35MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%